| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Chief Medical Officer | Common Stock | 82,850 | $7,650,369 | $92.34 | 10 Dec 2024 | Direct |
| GILEAD SCIENCES, INC. | Chief Medical Officer | Non-qualified Stock Option (Right to Buy) | 89,660 | $7,123,487 | $79.45 | 10 Mar 2024 | Direct |
| GILEAD SCIENCES, INC. | Chief Medical Officer | Restricted Stock Unit | 36,753 | $3,379,806 | $91.96 | 10 Dec 2024 | Direct |
| GILEAD SCIENCES, INC. | Chief Medical Officer | Restricted Stock Unit | 44,394 | $2,896,709 | $65.25 | 10 Jun 2024 | Direct |
| ARDELYX, INC. | Director | Common Stock | 57,291 | $207,393 | $3.62 | 18 Jun 2025 | Direct |
| Sagimet Biosciences Inc. | Director | Series A Common Stock | 12,794 | $52,455 | $4.10 | 18 Jul 2023 | Direct |
| ARDELYX, INC. | Director | Stock Option (Right to Buy) | 64,457 | 28 Apr 2025 | Direct | ||
| Sagimet Biosciences Inc. | Director | Stock Option (Right to Buy) | 51,459 | 05 Jun 2024 | Direct | ||
| ArriVent BioPharma, Inc. | Director | Stock Option (right to buy) | 28,346 | 28 Apr 2025 | Direct | ||
| ArriVent BioPharma, Inc. | Director | Non-Qualified Stock Option (right to buy) | 15,502 | 18 Jun 2025 | Direct | ||
| GILEAD SCIENCES, INC. | Chief Medical Officer | Non-qualified Stock Option (Right to Buy) | 196 | 27 Nov 2024 | Direct | ||
| Sagimet Biosciences Inc. | Director | Common Stock | 0 | 18 Jul 2023 | Direct | ||
| Sagimet Biosciences Inc. | Director | Series E Preferred Stock | 0 | 18 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARDX | ARDELYX, INC. | 18 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 20:41 |
| AVBP | ArriVent BioPharma, Inc. | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 19:33 |
| ARDX | ARDELYX, INC. | 28 Apr 2025 | 2 | $0 | 4 | Director | 14 May 2025, 19:51 |
| ARDX | ARDELYX, INC. | 28 Apr 2025 | 0 | $0 | 3 | Director | 13 May 2025, 21:47 |
| AVBP | ArriVent BioPharma, Inc. | 28 Apr 2025 | 1 | $0 | 4 | Director | 29 Apr 2025, 16:51 |
| AVBP | ArriVent BioPharma, Inc. | 28 Apr 2025 | 0 | $0 | 3 | Director | 29 Apr 2025, 16:49 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2024 | 3 | -$163,534 | 4 | Chief Medical Officer | 11 Dec 2024, 19:24 |
| GILD | GILEAD SCIENCES, INC. | 27 Nov 2024 | 9 | -$6,014,325 | 4 | Chief Medical Officer | 29 Nov 2024, 20:10 |
| GILD | GILEAD SCIENCES, INC. | 06 Nov 2024 | 4 | -$893,485 | 4 | Chief Medical Officer | 07 Nov 2024, 16:32 |
| GILD | GILEAD SCIENCES, INC. | 01 Oct 2024 | 1 | -$167,660 | 4 | Chief Medical Officer | 02 Oct 2024, 16:58 |
| GILD | GILEAD SCIENCES, INC. | 12 Sep 2024 | 3 | -$347,287 | 4 | Chief Medical Officer | 13 Sep 2024, 19:07 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2024 | 3 | -$143,823 | 4 | Chief Medical Officer | 11 Sep 2024, 19:33 |
| GILD | GILEAD SCIENCES, INC. | 01 Jul 2024 | 1 | -$137,260 | 4 | Chief Medical Officer | 01 Jul 2024, 20:06 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2024 | 3 | -$113,796 | 4 | Chief Medical Officer | 11 Jun 2024, 19:15 |
| SGMT | Sagimet Biosciences Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:07 |
| GILD | GILEAD SCIENCES, INC. | 01 Apr 2024 | 1 | -$145,920 | 4 | Chief Medical Officer | 02 Apr 2024, 18:38 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2024 | 7 | -$360,801 | 4 | Chief Medical Officer | 11 Mar 2024, 21:14 |
| GILD | GILEAD SCIENCES, INC. | 28 Feb 2024 | 2 | -$744,984 | 4 | Chief Medical Officer | 29 Feb 2024, 18:35 |
| GILD | GILEAD SCIENCES, INC. | 31 Jan 2024 | 3 | -$1,855,466 | 4 | Chief Medical Officer | 02 Feb 2024, 14:42 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2023 | 3 | -$100,276 | 4 | Chief Medical Officer | 11 Dec 2023, 19:10 |
| GILD | GILEAD SCIENCES, INC. | 12 Sep 2023 | 1 | -$115,562 | 4 | Chief Medical Officer | 13 Sep 2023, 19:50 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2023 | 3 | -$97,128 | 4 | Chief Medical Officer | 11 Sep 2023, 21:19 |
| SGMT | Sagimet Biosciences Inc. | 18 Jul 2023 | 14 | $0 | 4 | Director | 20 Jul 2023, 16:17 |
| SGMT | Sagimet Biosciences Inc. | 13 Jul 2023 | 0 | $0 | 3 | Director | 13 Jul 2023, 21:05 |
| GILD | GILEAD SCIENCES, INC. | 13 Jun 2023 | 1 | -$114,196 | 4 | Chief Medical Officer | 14 Jun 2023, 17:48 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2023 | 3 | -$101,087 | 4 | Chief Medical Officer | 12 Jun 2023, 16:45 |
| GILD | GILEAD SCIENCES, INC. | 13 Mar 2023 | 1 | -$483,893 | 4 | Chief Medical Officer | 14 Mar 2023, 18:20 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2023 | 7 | -$423,576 | 4 | Chief Medical Officer | 13 Mar 2023, 21:09 |
| GILD | GILEAD SCIENCES, INC. | 01 Mar 2023 | 1 | -$1,038,225 | 4 | Chief Medical Officer | 02 Mar 2023, 18:01 |
| GILD | GILEAD SCIENCES, INC. | 15 Feb 2023 | 1 | +$21,199 | 4 | Chief Medical Officer | 23 Feb 2023, 15:16 |
| GILD | GILEAD SCIENCES, INC. | 24 Jan 2023 | 3 | -$1,491,271 | 4 | Chief Medical Officer | 26 Jan 2023, 14:40 |
| GILD | GILEAD SCIENCES, INC. | 30 Dec 2022 | 1 | -$47,187 | 4 | Chief Medical Officer | 03 Jan 2023, 19:05 |
| GILD | GILEAD SCIENCES, INC. | 10 Dec 2022 | 3 | -$42,753 | 4 | Chief Medical Officer | 13 Dec 2022, 14:14 |
| GILD | GILEAD SCIENCES, INC. | 10 Nov 2022 | 3 | -$187,337 | 4 | Chief Medical Officer | 14 Nov 2022, 11:42 |
| GILD | GILEAD SCIENCES, INC. | 10 Sep 2022 | 3 | -$31,400 | 4 | Chief Medical Officer | 12 Sep 2022, 16:05 |
| GILD | GILEAD SCIENCES, INC. | 10 Jun 2022 | 3 | -$29,459 | 4 | Chief Medical Officer | 13 Jun 2022, 19:53 |
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2022 | 7 | -$203,010 | 4 | Chief Medical Officer | 14 Mar 2022, 21:20 |
| GILD | GILEAD SCIENCES, INC. | 15 Feb 2022 | 1 | +$18,141 | 4 | Chief Medical Officer | 13 Apr 2022, 20:32 |
| GILD | GILEAD SCIENCES INC | 26 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 28 Jan 2022, 19:51 |
| GILD | GILEAD SCIENCES INC | 10 Nov 2021 | 3 | -$156,182 | 4 | Chief Medical Officer | 12 Nov 2021, 17:01 |
| GILD | GILEAD SCIENCES INC | 15 Aug 2021 | 1 | +$55.08 | 4 | Chief Medical Officer | 24 Aug 2021, 18:12 |